Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques De Keyser

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
Neurology|April 4, 2007
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesMarcus W Koch, Jop P Mostert, Joeke J de Vries, et al.
JAMA Neurology|February 27, 2013
Successful repetitive intravenous thrombolysis in a patient with recurrent brainstem infarctions due to megadolichobasilar ectasiaMelissa Cambron, Robbert-Jan Van Hooff, Koenraad Nieboer, et al.
Stroke|August 12, 2006
Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1Nadine Wilczak, Jan Willem Elting, Daniel Chesik, et al.
Frontiers in Neurology|May 31, 2021
Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic StrokeRobin Gens, Anissa Ourtani, Aurelie De Vos, et al.
CNS Neuroscience & Therapeutics|April 16, 2016
Central IGF-I Receptors in the Brain are Instrumental to Neuroprotection by Systemically Injected IGF-I in a Rat Model for Ischemic StrokeDeborah De Geyter, Ann De Smedt, Wendy Stoop, et al.
Journal of Neurochemistry|July 19, 2002
Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary glandNadine Wilczak, Nicole Kühl, Daniel Chesik, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 1, 2010
Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatranAnn De Smedt, Sylvie De Raedt, Koenraad Nieboer, et al.
Stroke|January 4, 2003
Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot studyGeert Sulter, Jan Willem Elting, Marc Langedijk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Progression in familial and nonfamilial MSMarcus Koch, Maarten Uyttenboogaart, Marco Heerings, et al.
Stroke|July 28, 2007
Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situationsJacques De Keyser, Zuzana Gdovinová, Maarten Uyttenboogaart, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
Neurology|April 4, 2007
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesMarcus W Koch, Jop P Mostert, Joeke J de Vries, et al.
JAMA Neurology|February 27, 2013
Successful repetitive intravenous thrombolysis in a patient with recurrent brainstem infarctions due to megadolichobasilar ectasiaMelissa Cambron, Robbert-Jan Van Hooff, Koenraad Nieboer, et al.
Stroke|August 12, 2006
Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1Nadine Wilczak, Jan Willem Elting, Daniel Chesik, et al.
Frontiers in Neurology|May 31, 2021
Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic StrokeRobin Gens, Anissa Ourtani, Aurelie De Vos, et al.
CNS Neuroscience & Therapeutics|April 16, 2016
Central IGF-I Receptors in the Brain are Instrumental to Neuroprotection by Systemically Injected IGF-I in a Rat Model for Ischemic StrokeDeborah De Geyter, Ann De Smedt, Wendy Stoop, et al.
Journal of Neurochemistry|July 19, 2002
Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary glandNadine Wilczak, Nicole Kühl, Daniel Chesik, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 1, 2010
Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatranAnn De Smedt, Sylvie De Raedt, Koenraad Nieboer, et al.
Stroke|January 4, 2003
Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot studyGeert Sulter, Jan Willem Elting, Marc Langedijk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Progression in familial and nonfamilial MSMarcus Koch, Maarten Uyttenboogaart, Marco Heerings, et al.
Stroke|July 28, 2007
Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situationsJacques De Keyser, Zuzana Gdovinová, Maarten Uyttenboogaart, et al.
Pageof 18